Detection of antibodies against SARS-CoV in serum from SARS-infected donors with ELISA and Western blot

Recombinant fragments of S proteins from the Severe Acute Respiratory Syndrome (SARS) coronavirus (SARA-CoV) were generated and used in a Western blot (WB) assay that was compared to a commercial SARS ELISA method. In 85% of confirmed SARS cases (n = 20), the S2 recombinant fragment based WB was pos...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yue-Dan, Li, Yan, Xu, Guo-Bin, Dong, Xue-Yuan, Yang, Xiao-Ang, Feng, Zhen-Ru, Tian, Chan, Chen, Wei Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2004
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7106230/
https://www.ncbi.nlm.nih.gov/pubmed/15451470
http://dx.doi.org/10.1016/j.clim.2004.07.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7106230/
https://www.ncbi.nlm.nih.gov/pubmed/15451470
http://dx.doi.org/10.1016/j.clim.2004.07.003

Ejemplares similares